Obermeyer Wealth Partners
Source: SEC Form 13F · as of Mar 2026Obermeyer Wealth Partners holds 17 biotech & pharma companies tracked by BioSniper, totaling $58.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$58.9M
| Company | Shares | Value |
|---|---|---|
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 112,471 | $30.4M |
| ZTSZoetis Inc. | 89,399 | $10.6M |
| JNJJOHNSON & JOHNSON | 12,310 | $3.0M |
| ABBVAbbVie Inc. | 10,851 | $2.4M |
| AZNASTRAZENECA PLC | 11,584 | $2.3M |
| LLYELI LILLY & Co | 1,704 | $1.6M |
| AMGNAMGEN INC | 4,091 | $1.4M |
| ABTABBOTT LABORATORIES | 12,835 | $1.3M |
| IDXXIDEXX LABORATORIES INC /DE | 2,000 | $1.1M |
| MRKMerck & Co., Inc. | 8,610 | $1.0M |
| BMYBRISTOL MYERS SQUIBB CO | 15,553 | $943K |
| CORCencora Inc. | 2,699 | $848K |
| PFEPFIZER INC | 28,295 | $795K |
| PMPhilip Morris International Inc | 3,258 | $539K |
| GILDGILEAD SCIENCES, INC. | 2,943 | $410K |
| GMOptec International, Inc. | 3,484 | $260K |
| LUCDLucid Diagnostics Inc. | 13,000 | $15K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.